Pharmaceutical
| Sat 22 Aug 2026
Oslo, Aug. 22 -- Almirall SA has filed a patent application for Novel Compounds Activating the Nrf2 Pathway. This invention was developed by Puig Duran Carlos, Albericio Palomera Fernando, Gongora Benitez Miriam, Paradis Bas Marta, Miret Casals Laia, Ramos Tomillero Ivan, Fiacco Stephen, Davis Andrew, Geschwindner Stefan, Brun C..